APA (7th ed.) Citation

Bazhenova, L., Liu, S., Lin, J., Lu, S., Drilon, A., Chawla, S., . . . Springfeld, C. (2021). 533P Efficacy and safety of entrectinib in patients with locally advanced/metastatic NTRK fusion-positive (NTRK-fp) solid tumours. Annals of Oncology, 32, S598. https://doi.org/10.1016/j.annonc.2021.08.1055

Chicago Style (17th ed.) Citation

Bazhenova, L., et al. "533P Efficacy and Safety of Entrectinib in Patients with Locally Advanced/metastatic NTRK Fusion-positive (NTRK-fp) Solid Tumours." Annals of Oncology 32 (2021): S598. https://doi.org/10.1016/j.annonc.2021.08.1055.

MLA (9th ed.) Citation

Bazhenova, L., et al. "533P Efficacy and Safety of Entrectinib in Patients with Locally Advanced/metastatic NTRK Fusion-positive (NTRK-fp) Solid Tumours." Annals of Oncology, vol. 32, 2021, p. S598, https://doi.org/10.1016/j.annonc.2021.08.1055.